Stein Ivar Hallan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Stein Ivar Hallan has a total of 192 co-authors. Here are the top co-authors by number of shared publications:
Joachim H. Ix
Division of Nephrology-Hypertension, Department of Medicine, University of California San Diego
5 shared publicationsKnut A. Langlo
Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway
5 shared publications- Knut Asbjørn Rise Langlo
Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway
5 shared publications Marius A. Øvrehus
Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway
5 shared publications- Michael G. Shlipak
Kidney Health Research Collaborative, Department of Medicine University of California San Francisco San Francisco California USA
5 shared publications - Friedo Wilhelm Dekker
Department of Clinical Epidemiology, Leiden University Medical Center , Leiden
4 shared publications
Latest Publications
- Open Access
Exploring the Causal Relationship Between Body Mass Index and Kidney Function: Tissue-Partitioned Mendelian Randomization
Background: Chronic kidney disease (CKD) represents a leading non-communicable disease, significantly contributing to global morbidity and mortality. Mendelian randomization studies (MR) have been integral in providing robust evidence that increased body mass index (BMI) has a causal impact on CKD. However, dissecting which specific mechanisms are primarily consistent with disease development remains challenging, and tissue-partitioned genetic analyses may provide exploratory insight into this underlying biological architecture. Objective: To investigate whether BMI-associated genetic variants prioritized according to colocalization with brain or subcutaneous adipose tissue gene expression exhibit differential associations with kidney function using tissue-partitioned MR. Methods: We employ a two-sample univariable and multivariable MR (MVMR) methodology that segregates genetic variants associated with BMI based on colocalization with gene expression in either brain or subcutaneous adipose tissue. We utilize sets of adipose and brain expression quantitative trait loci (eQTLs) that demonstrated colocalization with BMI (88 and 141 SNPs, respectively). We also use GWAS summary statistics of creatinine and cystatin C-based eGFR (eGFRcrea; n = 1,004,040 and eGFRcys; n = 460,826) blood urea nitrogen (BUN; n = 852,678), eGFR decline (n = 343,339) and CKD (defined as eGFRcrea < 60 mL/min/1.73m2; 41,395 cases and 439,303 controls) of European ancestry. Results: Univariable MR showed consistent positive associations between BMI and CKD (OR = 1.17, 95% CI: 1.1 to 1.23) and inverse associations with eGFRcys (beta = −0.051, 95% CI: −0.056 to −0.047). Both brain- and adipose-instrumented BMI showed similar effect sizes. However, MVMR provided no evidence that either tissue-partitioned BMI component exhibited a distinguishable association with CKD after mutual adjustment, (ORadipose = 1.2, 95% CIadipose = 0.87 to 1.7, ORbrain = 1.18, 95% CIbrain = 0.9 to 1.55) or other kidney function traits. Conclusions: While genetically predicted BMI was associated with kidney function, our tissue-partitioned MR analysis found no evidence that BMI genetic variants prioritized according to brain or subcutaneous adipose tissue gene expression exhibited distinguishable associations with kidney outcomes in MVMR. These findings may reflect shared genetic architecture, limited ability to distinguish highly correlated tissue-partitioned BMI components, or insufficient power to detect modest differences between them.
Open AccessExploring the Causal Relationship Between Body Mass Index and Kidney Function: Tissue-Partitioned Mendelian Randomization
Background: Chronic kidney disease (CKD) represents a leading non-communicable disease, significantly contributing to global morbidity and mortality. Mendelian randomization studies (MR) have been integral in providing robust evidence that increased body mass index (BMI) has a causal impact on CKD. However, dissecting which specific mechanisms are primarily consistent with disease development remains challenging, and tissue-partitioned genetic analyses may provide exploratory insight into this underlying biological architecture. Objective: To investigate whether BMI-associated genetic variants prioritized according to colocalization with brain or subcutaneous adipose tissue gene expression exhibit differential associations with kidney function using tissue-partitioned MR. Methods: We employ a two-sample univariable and multivariable MR (MVMR) methodology that segregates genetic variants associated with BMI based on colocalization with gene expression in either brain or subcutaneous adipose tissue. We utilize sets of adipose and brain expression quantitative trait loci (eQTLs) that demonstrated colocalization with BMI (88 and 141 SNPs, respectively). We also use GWAS summary statistics of creatinine and cystatin C-based eGFR (eGFRcrea; n = 1,004,040 and eGFRcys; n = 460,826) blood urea nitrogen (BUN; n = 852,678), eGFR decline (n = 343,339) and CKD (defined as eGFRcrea < 60 mL/min/1.73m2; 41,395 cases and 439,303 controls) of European ancestry. Results: Univariable MR showed consistent positive associations between BMI and CKD (OR = 1.17, 95% CI: 1.1 to 1.23) and inverse associations with eGFRcys (beta = −0.051, 95% CI: −0.056 to −0.047). Both brain- and adipose-instrumented BMI showed similar effect sizes. However, MVMR provided no evidence that either tissue-partitioned BMI component exhibited a distinguishable association with CKD after mutual adjustment, (ORadipose = 1.2, 95% CIadipose = 0.87 to 1.7, ORbrain = 1.18, 95% CIbrain = 0.9 to 1.55) or other kidney function traits. Conclusions: While genetically predicted BMI was associated with kidney function, our tissue-partitioned MR analysis found no evidence that BMI genetic variants prioritized according to brain or subcutaneous adipose tissue gene expression exhibited distinguishable associations with kidney outcomes in MVMR. These findings may reflect shared genetic architecture, limited ability to distinguish highly correlated tissue-partitioned BMI components, or insufficient power to detect modest differences between them.
- 20 August 2026
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
Kidney Tubular Secretion Capacity and Risk of Cardiovascular Mortality in the General Population
Key Points: For the first time, we evaluated the association between kidney secretion and cardiovascular mortality in community-dwelling individuals. Worse tubular secretion was associated with a greater mortality risk, independent of eGFR, albuminuria, and other traditional risk factors. The association between worse tubular secretion and cardiovascular disease mortality was similar across major demographic categories. Background: Kidney tubular secretion is a critical mechanism for the clearance of numerous metabolites, toxins, and drugs. In populations with advanced CKD, low (worse) tubular secretion has been associated with an increased risk of cardiovascular disease (CVD). However, it remains unknown whether this relationship is also present in the general population. Methods: In this case–cohort study, we selected a 10% random subcohort ( n =1246) from the Nord-Trøndelag Health Study-3 (a Norwegian community-dwelling population cohort) and we also sampled 141 CVD death cases that occurred outside of the subcohort. We developed a summary secretion score by averaging urine-to-plasma ratios of 12 endogenous secreted solutes, with lower ratios indicating worse tubular secretion. Weighted Cox proportional hazards models were used to assess the relationship between the summary secretion score and the risk of CVD mortality. Results: The mean (SD) age was 51 (14) years, 54.4% were female, 6% had prevalent CVD, and median (interquartile range) eGFR was 99 (90–110) ml/min per 1.73 m 2 at baseline. In multivariable models adjusted for demographics, CVD risk factors, eGFR, and albuminuria, each SD lower summary secretion score was associated with 27% higher risk of CVD mortality (95% confidence interval, 1.03 to 1.56). The results were similar across major demographic categories and among those with or without eGFR 30 mg/g at baseline. Conclusions: Among community-dwelling participants, lower tubular secretion is associated with increased CVD mortality independent of eGFR, albuminuria, and other CKD risk factors.
- 20 August 2026
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
Kidney Tubular Secretion Capacity and Risk of Cardiovascular Mortality in the General Population
Key Points: For the first time, we evaluated the association between kidney secretion and cardiovascular mortality in community-dwelling individuals. Worse tubular secretion was associated with a greater mortality risk, independent of eGFR, albuminuria, and other traditional risk factors. The association between worse tubular secretion and cardiovascular disease mortality was similar across major demographic categories. Background: Kidney tubular secretion is a critical mechanism for the clearance of numerous metabolites, toxins, and drugs. In populations with advanced CKD, low (worse) tubular secretion has been associated with an increased risk of cardiovascular disease (CVD). However, it remains unknown whether this relationship is also present in the general population. Methods: In this case–cohort study, we selected a 10% random subcohort ( n =1246) from the Nord-Trøndelag Health Study-3 (a Norwegian community-dwelling population cohort) and we also sampled 141 CVD death cases that occurred outside of the subcohort. We developed a summary secretion score by averaging urine-to-plasma ratios of 12 endogenous secreted solutes, with lower ratios indicating worse tubular secretion. Weighted Cox proportional hazards models were used to assess the relationship between the summary secretion score and the risk of CVD mortality. Results: The mean (SD) age was 51 (14) years, 54.4% were female, 6% had prevalent CVD, and median (interquartile range) eGFR was 99 (90–110) ml/min per 1.73 m 2 at baseline. In multivariable models adjusted for demographics, CVD risk factors, eGFR, and albuminuria, each SD lower summary secretion score was associated with 27% higher risk of CVD mortality (95% confidence interval, 1.03 to 1.56). The results were similar across major demographic categories and among those with or without eGFR 30 mg/g at baseline. Conclusions: Among community-dwelling participants, lower tubular secretion is associated with increased CVD mortality independent of eGFR, albuminuria, and other CKD risk factors.
- Top Cited PapersOpen Access
- 30 January 2026
- Published by Elsevier in Kidney International Reports
- Vol. 11 (4) , 103801
Proximal Tubule Reabsorption and CKD Progression in the General Population
- 30 January 2026
- Published by Elsevier in Kidney International Reports
- Vol. 11 (4) , 103801
Top Cited PapersOpen AccessProximal Tubule Reabsorption and CKD Progression in the General Population
- 26 December 2025
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 21 (11) , 2051-2061
Comparing Age- and Sex-Specific Reference Values of eGFR between the United States and Europe
The extent to which eGFR varies across populations, in the absence of risk factors and comorbidities associated with kidney disease, remains uncertain. We aimed to develop eGFR reference values in healthy American adults and to compare them with previously described European eGFR reference values. This cross-sectional study compared newly described age-specific and sex-specific creatinine-based eGFR reference values from over 9000 healthy Americans from National Health and Nutrition Examination Survey with previously described eGFR reference values from over 1.5 million healthy individuals in the European CKD Burden Consortium. Health status was based on 14 criteria related to comorbidities, lifestyle factors, and medication use. eGFR was calculated using the European Kidney Function Consortium equation and modeled over the age span and by sex using a generalized additive model. The median eGFR in both 20-year-old American and European men was 98 ml/min per 1.73 m 2 . In both 20-year-old American and European women, the median eGFR was 101 ml/min per 1.73 m 2 . eGFR started to decrease at age 40 years, a result of the structure of the European Kidney Function Consortium equation. By age 79 years, the median eGFR in American and European men was 68 and 67 ml/min per 1.73 m 2 , respectively. The median eGFR in 79-year-old American and European women was 63 and 64 ml/min per 1.73 m 2 , respectively. When removing the effect of comorbidities, lifestyle factors and medication use associated with kidney function, achieved by restricting the analyses to individuals who did not have a presence or history of certain criteria, the distribution of eGFR was similar between healthy Americans and Europeans. This supports the notion that eGFR reference values may be generalizable to populations they were not derived from.
- 26 December 2025
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 21 (11) , 2051-2061
Comparing Age- and Sex-Specific Reference Values of eGFR between the United States and Europe
The extent to which eGFR varies across populations, in the absence of risk factors and comorbidities associated with kidney disease, remains uncertain. We aimed to develop eGFR reference values in healthy American adults and to compare them with previously described European eGFR reference values. This cross-sectional study compared newly described age-specific and sex-specific creatinine-based eGFR reference values from over 9000 healthy Americans from National Health and Nutrition Examination Survey with previously described eGFR reference values from over 1.5 million healthy individuals in the European CKD Burden Consortium. Health status was based on 14 criteria related to comorbidities, lifestyle factors, and medication use. eGFR was calculated using the European Kidney Function Consortium equation and modeled over the age span and by sex using a generalized additive model. The median eGFR in both 20-year-old American and European men was 98 ml/min per 1.73 m 2 . In both 20-year-old American and European women, the median eGFR was 101 ml/min per 1.73 m 2 . eGFR started to decrease at age 40 years, a result of the structure of the European Kidney Function Consortium equation. By age 79 years, the median eGFR in American and European men was 68 and 67 ml/min per 1.73 m 2 , respectively. The median eGFR in 79-year-old American and European women was 63 and 64 ml/min per 1.73 m 2 , respectively. When removing the effect of comorbidities, lifestyle factors and medication use associated with kidney function, achieved by restricting the analyses to individuals who did not have a presence or history of certain criteria, the distribution of eGFR was similar between healthy Americans and Europeans. This supports the notion that eGFR reference values may be generalizable to populations they were not derived from.
- Open Access
- 27 October 2025
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 21 (3) , 460-470
Plasma Biomarkers of Kidney Tubule Health during Ambulatory AKI and Kidney Function Recovery in SPRINT
Key Points: AKI frequently occurs in the ambulatory setting, but there are no available tools to distinguish whether kidney function will recover. Plasma biomarkers reflecting kidney tubular injury and dysfunction measured at the time of AKI are associated with nonrecovery in kidney function. Measuring plasma biomarkers of kidney tubule health during ambulatory AKI episodes could be helpful in guiding treatment decisions. Background: AKI frequently occurs in the ambulatory setting, but few tools are available to distinguish whether an individual's kidney function will subsequently recover. Methods: We included 652 participants with and without CKD in the Systolic Blood Pressure Intervention Trial who experienced ambulatory AKI, defined as a rise in serum creatinine of ≥0.3 mg/dl from baseline that occurred at the 12- or 24-month study visits. Four plasma biomarkers of kidney tubule health were measured at baseline and when ambulatory AKI was detected: kidney injury molecule-1 (KIM-1), soluble TNF receptor 1 (sTNFR1) and soluble TNF receptor 2, and uromodulin. Multivariable logistic regression models were used to evaluate biomarker associations with subsequent odds of 2 , and there was an eGFR decline of 21.7±12.5 ml/min per 1.73 m 2 at the time ambulatory AKI was detected. When measured at the time of ambulatory AKI, higher KIM-1 (odds ratio [OR], 1.40; 95% confidence interval [CI], 1.14 to 1.73) and sTNFR1 (OR, 2.07; 95% CI, 1.49 to 2.88) and lower uromodulin (OR, 0.77; 95% CI, 0.63 to 0.94) were each associated with eGFR nonrecovery in multivariable models that adjusted for eGFR and albuminuria. In models that included all four plasma biomarkers, KIM-1 and sTNFR1 remained jointly associated with eGFR nonrecovery. Conclusions: Among hypertensive adults with ambulatory AKI, plasma biomarkers reflecting impaired kidney tubule health measured at the time of ambulatory AKI are associated with subsequent nonrecovery in kidney function.
- 27 October 2025
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 21 (3) , 460-470
Open AccessPlasma Biomarkers of Kidney Tubule Health during Ambulatory AKI and Kidney Function Recovery in SPRINT
Key Points: AKI frequently occurs in the ambulatory setting, but there are no available tools to distinguish whether kidney function will recover. Plasma biomarkers reflecting kidney tubular injury and dysfunction measured at the time of AKI are associated with nonrecovery in kidney function. Measuring plasma biomarkers of kidney tubule health during ambulatory AKI episodes could be helpful in guiding treatment decisions. Background: AKI frequently occurs in the ambulatory setting, but few tools are available to distinguish whether an individual's kidney function will subsequently recover. Methods: We included 652 participants with and without CKD in the Systolic Blood Pressure Intervention Trial who experienced ambulatory AKI, defined as a rise in serum creatinine of ≥0.3 mg/dl from baseline that occurred at the 12- or 24-month study visits. Four plasma biomarkers of kidney tubule health were measured at baseline and when ambulatory AKI was detected: kidney injury molecule-1 (KIM-1), soluble TNF receptor 1 (sTNFR1) and soluble TNF receptor 2, and uromodulin. Multivariable logistic regression models were used to evaluate biomarker associations with subsequent odds of 2 , and there was an eGFR decline of 21.7±12.5 ml/min per 1.73 m 2 at the time ambulatory AKI was detected. When measured at the time of ambulatory AKI, higher KIM-1 (odds ratio [OR], 1.40; 95% confidence interval [CI], 1.14 to 1.73) and sTNFR1 (OR, 2.07; 95% CI, 1.49 to 2.88) and lower uromodulin (OR, 0.77; 95% CI, 0.63 to 0.94) were each associated with eGFR nonrecovery in multivariable models that adjusted for eGFR and albuminuria. In models that included all four plasma biomarkers, KIM-1 and sTNFR1 remained jointly associated with eGFR nonrecovery. Conclusions: Among hypertensive adults with ambulatory AKI, plasma biomarkers reflecting impaired kidney tubule health measured at the time of ambulatory AKI are associated with subsequent nonrecovery in kidney function.
- 15 September 2025
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 36 (11) , 2310
Authors' Reply: Interpreting Rapid eGFR Decline in the Generation 100 Study
- 15 September 2025
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 36 (11) , 2310
Authors' Reply: Interpreting Rapid eGFR Decline in the Generation 100 Study
- 15 September 2025
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 36 (11) , 2312
Authors' Reply: Reconsidering Biomarker Interpretation and Clinical Applicability in High-Intensity Interval Training and Kidney Function Trials
- 15 September 2025
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 36 (11) , 2312
Authors' Reply: Reconsidering Biomarker Interpretation and Clinical Applicability in High-Intensity Interval Training and Kidney Function Trials
- Open Access
- 3 September 2025
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 20 (11) , 1571-1583
Regular Physical Activity is Associated with Slower Age-Related Iohexol Clearance Decline in the General Population without Diabetes
Key Points: Higher self-reported physical activity is associated with a slower annual GFR decline in the general population. Those who were physically active almost daily had a much lower risk of rapid kidney function decline compared with inactive individuals. These findings suggest that regular physical activity could be a cost-effective way to help reduce the global burden of CKD. Background: CKD prevalence is rising globally due to an aging population. The role of physical activity (PA) in slowing age-related kidney function decline in the general population remains undecided. Methods: In the longitudinal Renal Iohexol Clearance Survey cohort, we investigated 1837 individuals without self-reported diabetes, cardiovascular disease, or kidney disease at baseline. Participants underwent repeated GFR measurements over 11 years using iohexol clearance. Baseline PA was assessed with the PA frequency, intensity, and duration questionnaire. Linear mixed models and multiple logistic regression examined the relationship between PA and the GFR change rate and accelerated GFR decline (the steepest 10% of GFR slopes). Results: The median measured GFR (mGFR) decline was −1.06 ml/min per 1.73 m 2 per year (interquartile range, −1.31 to −0.80). Higher PA frequency was associated with 71% lower odds of accelerated GFR decline (odds ratio, 0.29; 95% confidence interval, 0.11 to 0.78) compared with those not engaging in PA, after adjustment. PA frequency and meeting the World Health Organization PA recommendations were associated with a slower annual mGFR decline rate before adjusting for smoking and alcohol consumption, with a dose-response trend with increasing PA frequency ( P = 0.001). Individuals engaging in approximately daily PA had a slower mGFR decline by 0.47 ml/min per 1.73 m 2 per year (95% confidence interval, 0.13 to 0.80; P = 0.006). Conclusions: Increasing PA frequency was associated with a slower mean mGFR decline and a lower risk of accelerated mGFR decline. Promoting regular PA should be prioritized as a low-cost, high-impact strategy to reduce the global CKD burden.
- 3 September 2025
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 20 (11) , 1571-1583
Open AccessRegular Physical Activity is Associated with Slower Age-Related Iohexol Clearance Decline in the General Population without Diabetes
Key Points: Higher self-reported physical activity is associated with a slower annual GFR decline in the general population. Those who were physically active almost daily had a much lower risk of rapid kidney function decline compared with inactive individuals. These findings suggest that regular physical activity could be a cost-effective way to help reduce the global burden of CKD. Background: CKD prevalence is rising globally due to an aging population. The role of physical activity (PA) in slowing age-related kidney function decline in the general population remains undecided. Methods: In the longitudinal Renal Iohexol Clearance Survey cohort, we investigated 1837 individuals without self-reported diabetes, cardiovascular disease, or kidney disease at baseline. Participants underwent repeated GFR measurements over 11 years using iohexol clearance. Baseline PA was assessed with the PA frequency, intensity, and duration questionnaire. Linear mixed models and multiple logistic regression examined the relationship between PA and the GFR change rate and accelerated GFR decline (the steepest 10% of GFR slopes). Results: The median measured GFR (mGFR) decline was −1.06 ml/min per 1.73 m 2 per year (interquartile range, −1.31 to −0.80). Higher PA frequency was associated with 71% lower odds of accelerated GFR decline (odds ratio, 0.29; 95% confidence interval, 0.11 to 0.78) compared with those not engaging in PA, after adjustment. PA frequency and meeting the World Health Organization PA recommendations were associated with a slower annual mGFR decline rate before adjusting for smoking and alcohol consumption, with a dose-response trend with increasing PA frequency ( P = 0.001). Individuals engaging in approximately daily PA had a slower mGFR decline by 0.47 ml/min per 1.73 m 2 per year (95% confidence interval, 0.13 to 0.80; P = 0.006). Conclusions: Increasing PA frequency was associated with a slower mean mGFR decline and a lower risk of accelerated mGFR decline. Promoting regular PA should be prioritized as a low-cost, high-impact strategy to reduce the global CKD burden.
- 2 April 2025
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 36 (7) , 1454-1455
Authors' Reply: Balancing Feasibility and Efficacy: Reflections on Exercise Interventions for CKD Prevention in Older Adults
- 2 April 2025
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 36 (7) , 1454-1455
Authors' Reply: Balancing Feasibility and Efficacy: Reflections on Exercise Interventions for CKD Prevention in Older Adults
- Top Cited PapersOpen Access
- 11 February 2025
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 36 (7) , 1352-1362
Long-Term Physical Exercise for Preventing CKD in Older Adults
Key Points: Physical exercise mitigates several kidney-related pathophysiological pathways, yet its effect on kidney function remains underexplored. This randomized clinical trial found that high-intensity interval training significantly reduced the risk of rapid eGFR decline in older adults. Physical exercise can preserve kidney function, benefiting public health and individual patient outcomes similar to other cardiovascular diseases. Background: CKD is a growing global public health issue. Physical exercise mitigates several kidney-related pathophysiological pathways, yet its effect on kidney function remains underexplored. We investigated the dose-response effect of physical exercise on kidney function preservation in older adults. Methods: We conducted a post hoc analysis of the Generation 100 Study, a 5-year open-label, randomized, parallel-arm clinical trial conducted from 2012 to 2018 in Trondheim, Norway. All inhabitants aged 70–77 years were invited ( n =6966). Main exclusion criteria were dementia; severe, uncontrolled cardiovascular disease or hypertension; or conditions precluding exercise. The control group ( n =385) received information on national physical activity recommendations. Intervention groups underwent supervised moderate-intensity continuous training (70% of peak heart rate) for 50 minutes ( n =380) twice weekly for 5 years or high-intensity interval training (90% of peak heart rate) for 4 minutes ×4 ( n =391) twice weekly for 5 years. The primary outcome was cystatin C–based rapid eGFR decline (>5 ml/min per 1.73 m 2 per year). Results: A total of 1156 participants were randomized, with median (interquartile range) age 72 (3) years and eGFR 95 (20) ml/min per 1.73 m 2 . Oxygen uptake increased by 1.8, 2.3, and 3.3 ml/kg per minutes in the control, moderate-intensity, and high-intensity groups, respectively. Rapid eGFR decline occurred in 117 (30%), 108 (28%), and 92 (23%) participants, respectively. Compared with controls, relative risk (RR) was 0.93 (95% confidence interval [CI], 0.75 to 1.16) for the moderate-intensity and 0.75 (95% CI, 0.59 to 0.95) for high-intensity groups, demonstrating a significant dose-response relationship ( P for trend 0.02). In observational analyses, participants with decreasing moderate-to-vigorous intensity activity (>−20 min/wk) had RR 1.30 (95% CI, 0.93 to 1.83) for rapid eGFR decline, while those with increasing activity (>+20 min/wk) had RR 0.73 (95% CI, 0.53 to 0.99) compared with stable activity after adjusting for baseline age, sex, peak oxygen uptake, and eGFR. Conclusions: High-intensity interval training significantly reduced the risk of rapid eGFR decline in older adults. Clinical Trial registry name and registration number: ClinicalTrials.gov: NCT01666340.
- 11 February 2025
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 36 (7) , 1352-1362
Top Cited PapersOpen AccessLong-Term Physical Exercise for Preventing CKD in Older Adults
Key Points: Physical exercise mitigates several kidney-related pathophysiological pathways, yet its effect on kidney function remains underexplored. This randomized clinical trial found that high-intensity interval training significantly reduced the risk of rapid eGFR decline in older adults. Physical exercise can preserve kidney function, benefiting public health and individual patient outcomes similar to other cardiovascular diseases. Background: CKD is a growing global public health issue. Physical exercise mitigates several kidney-related pathophysiological pathways, yet its effect on kidney function remains underexplored. We investigated the dose-response effect of physical exercise on kidney function preservation in older adults. Methods: We conducted a post hoc analysis of the Generation 100 Study, a 5-year open-label, randomized, parallel-arm clinical trial conducted from 2012 to 2018 in Trondheim, Norway. All inhabitants aged 70–77 years were invited ( n =6966). Main exclusion criteria were dementia; severe, uncontrolled cardiovascular disease or hypertension; or conditions precluding exercise. The control group ( n =385) received information on national physical activity recommendations. Intervention groups underwent supervised moderate-intensity continuous training (70% of peak heart rate) for 50 minutes ( n =380) twice weekly for 5 years or high-intensity interval training (90% of peak heart rate) for 4 minutes ×4 ( n =391) twice weekly for 5 years. The primary outcome was cystatin C–based rapid eGFR decline (>5 ml/min per 1.73 m 2 per year). Results: A total of 1156 participants were randomized, with median (interquartile range) age 72 (3) years and eGFR 95 (20) ml/min per 1.73 m 2 . Oxygen uptake increased by 1.8, 2.3, and 3.3 ml/kg per minutes in the control, moderate-intensity, and high-intensity groups, respectively. Rapid eGFR decline occurred in 117 (30%), 108 (28%), and 92 (23%) participants, respectively. Compared with controls, relative risk (RR) was 0.93 (95% confidence interval [CI], 0.75 to 1.16) for the moderate-intensity and 0.75 (95% CI, 0.59 to 0.95) for high-intensity groups, demonstrating a significant dose-response relationship ( P for trend 0.02). In observational analyses, participants with decreasing moderate-to-vigorous intensity activity (>−20 min/wk) had RR 1.30 (95% CI, 0.93 to 1.83) for rapid eGFR decline, while those with increasing activity (>+20 min/wk) had RR 0.73 (95% CI, 0.53 to 0.99) compared with stable activity after adjusting for baseline age, sex, peak oxygen uptake, and eGFR. Conclusions: High-intensity interval training significantly reduced the risk of rapid eGFR decline in older adults. Clinical Trial registry name and registration number: ClinicalTrials.gov: NCT01666340.